Rei Tsang Shiao

Array ( [id] => 7265091 [patent_doc_number] => 20040242627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => '2-Iminoimidazole derivatives (1)' [patent_app_type] => new [patent_app_number] => 10/475045 [patent_app_country] => US [patent_app_date] => 2004-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40625 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242627.pdf [firstpage_image] =>[orig_patent_app_number] => 10475045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7156130 [patent_doc_number] => 20050026907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease' [patent_app_type] => utility [patent_app_number] => 10/865743 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15534 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026907.pdf [firstpage_image] =>[orig_patent_app_number] => 10865743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460601 [patent_doc_number] => 07241917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => '1-calcium phosphate-uracil and method for preparing thereof' [patent_app_type] => utility [patent_app_number] => 10/865095 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 2524 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241917.pdf [firstpage_image] =>[orig_patent_app_number] => 10865095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088463 [patent_doc_number] => 20050008575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Chelants and macrocyclic metal complex radiopharmaceuticals thereof' [patent_app_type] => utility [patent_app_number] => 10/864857 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35049 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008575.pdf [firstpage_image] =>[orig_patent_app_number] => 10864857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448918 [patent_doc_number] => 07250444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Pyrrole-based HMG-CoA reductase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/862844 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26206 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250444.pdf [firstpage_image] =>[orig_patent_app_number] => 10862844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378018 [patent_doc_number] => 20040220149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Nerve cell survival promoters containing cyclic phosphatidic acid derivative' [patent_app_type] => new [patent_app_number] => 10/474027 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9195 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220149.pdf [firstpage_image] =>[orig_patent_app_number] => 10474027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155107 [patent_doc_number] => 20070037990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Method of producing an organic compound comprising at least one oxygenated functional group' [patent_app_type] => utility [patent_app_number] => 10/558771 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2089 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037990.pdf [firstpage_image] =>[orig_patent_app_number] => 10558771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24096 [patent_doc_number] => 07795296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Crystals of non-natural-type stereoisomer salt of monatin and use thereof' [patent_app_type] => utility [patent_app_number] => 10/856756 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 16841 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795296.pdf [firstpage_image] =>[orig_patent_app_number] => 10856756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 456804 [patent_doc_number] => 07244758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'N-type calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/856921 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 3 [patent_no_of_words] => 11498 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244758.pdf [firstpage_image] =>[orig_patent_app_number] => 10856921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484533 [patent_doc_number] => 07902176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders' [patent_app_type] => utility [patent_app_number] => 10/567543 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 34679 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902176.pdf [firstpage_image] =>[orig_patent_app_number] => 10567543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378893 [patent_doc_number] => 20040220244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Oxa(thia)zolidine derivatives and anti-inflammatory drugs' [patent_app_type] => new [patent_app_number] => 10/853829 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15477 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220244.pdf [firstpage_image] =>[orig_patent_app_number] => 10853829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630476 [patent_doc_number] => 07132437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension' [patent_app_type] => utility [patent_app_number] => 10/852711 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 70728 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132437.pdf [firstpage_image] =>[orig_patent_app_number] => 10852711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630588 [patent_doc_number] => 07132549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Process' [patent_app_type] => utility [patent_app_number] => 10/852038 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 7611 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132549.pdf [firstpage_image] =>[orig_patent_app_number] => 10852038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089715 [patent_doc_number] => 20050009828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Azaindole-derivatives as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 10/849089 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33229 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009828.pdf [firstpage_image] =>[orig_patent_app_number] => 10849089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926594 [patent_doc_number] => 20050239851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Substituted benzoxazoles as estrogenic agents' [patent_app_type] => utility [patent_app_number] => 10/847100 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26946 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239851.pdf [firstpage_image] =>[orig_patent_app_number] => 10847100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117237 [patent_doc_number] => 20050070538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Compounds and uses thereof in modulating amyloid beta' [patent_app_type] => utility [patent_app_number] => 10/846941 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26807 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070538.pdf [firstpage_image] =>[orig_patent_app_number] => 10846941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149701 [patent_doc_number] => 20070049761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Substituted phosphonate fluorescent sensors and use thereof' [patent_app_type] => utility [patent_app_number] => 10/557073 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12120 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049761.pdf [firstpage_image] =>[orig_patent_app_number] => 10557073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265338 [patent_doc_number] => 20040242874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Process for synthesizing beta-lactamase inhibitor intermediates' [patent_app_type] => new [patent_app_number] => 10/844243 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11904 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242874.pdf [firstpage_image] =>[orig_patent_app_number] => 10844243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 401259 [patent_doc_number] => 07291624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-06 [patent_title] => 'CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents' [patent_app_type] => utility [patent_app_number] => 10/842419 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25116 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291624.pdf [firstpage_image] =>[orig_patent_app_number] => 10842419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698974 [patent_doc_number] => 20080221158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Novel 14 and 15 Membered Ring Compounds' [patent_app_type] => utility [patent_app_number] => 10/556709 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13396 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221158.pdf [firstpage_image] =>[orig_patent_app_number] => 10556709 [rel_patent_id] =>[rel_patent_doc_number] =>)